XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://xconomy.com/san-diego/2020/07/31/anaptysbio-appoints-paul-lizzul-as-its-first-chief-medical-officer/60%Monthly2020-07-31 21:29
https://xconomy.com/national/2020/07/31/bio-roundup-cerevels-shell-thrives-rise-drug-price-drama-more/60%Monthly2020-07-31 16:06
https://xconomy.com/san-francisco/2020/07/30/novartis-pays-75m-to-get-hands-on-sangamos-zinc-fingers-for-drug-rd/60%Monthly2020-07-31 00:34
https://xconomy.com/national/2020/07/30/arcutis-taps-verricas-burnett-to-succeed-retiring-chief-medical-officer/60%Monthly2020-07-30 20:23
https://xconomy.com/boston/2020/07/30/allovirs-ipo-raises-276m-to-test-cell-therapies-in-transplant-patients/60%Monthly2020-07-31 19:25
https://xconomy.com/san-diego/2020/07/29/amid-boom-days-for-biotech-inhibrx-lines-up-another-ipo-effort/60%Monthly2020-07-30 00:05
https://xconomy.com/europe/2020/07/29/roche-pays-120m-for-rights-to-ucbs-tau-targeting-alzheimers-drug/60%Monthly2020-08-20 19:34
https://xconomy.com/national/2020/07/29/2020-national-xconomy-awards-finalists-announced/60%Monthly2020-07-29 18:13
https://xconomy.com/boston/2020/07/29/omega-therapeutics-lands-85m-to-tap-into-control-room-for-biology/60%Monthly2020-07-29 14:06
https://xconomy.com/san-francisco/2020/07/29/nura-bio-debuts-with-73m-and-plan-to-develop-neuroprotective-drugs/60%Monthly2020-07-29 18:36
https://xconomy.com/national/2020/07/29/thrive-adds-257m-plans-pivotal-trial-of-early-cancer-detection-test/60%Monthly2020-08-06 16:44
https://xconomy.com/new-york/2020/07/28/pfizer-biontech-choose-full-spike-protein-for-pivotal-vaccine-test/60%Monthly2020-07-28 16:47
https://xconomy.com/san-diego/2020/07/27/telehealth-firm-aristamd-adds-24m-to-link-primary-docs-with-specialists/60%Monthly2020-07-28 02:50
https://xconomy.com/europe/2020/07/27/astrazeneca-to-pay-1b-to-team-up-with-daiichi-sankyo-again-in-cancer/60%Monthly2020-07-27 20:13
https://xconomy.com/san-diego/2020/07/27/avidity-biosciences-appoints-alnylams-jae-kim-as-chief-medical-officer/60%Monthly2020-07-27 19:33
https://xconomy.com/national/2020/07/27/clinical-trial-diversity-isnt-just-a-moral-issue-its-a-scientific-imperative/60%Monthly2020-07-25 02:19
https://xconomy.com/san-francisco/2020/07/24/gilead-gets-a-second-car-t-approval-this-time-for-mantle-cell-lymphoma/60%Monthly2020-07-24 22:30
https://xconomy.com/national/2020/07/24/bio-roundup-jazz-drug-okd-gileads-bet-moderna-patent-decision-more/60%Monthly2020-07-24 16:16
https://xconomy.com/boston/2020/07/23/scholar-rocks-alan-buckler-joins-triplet-as-chief-scientific-officer/60%Monthly2020-07-23 20:14
https://xconomy.com/san-francisco/2020/07/23/fda-lifts-cymabay-drug-hold-tests-to-resume-in-rare-liver-disease-pbc/60%Monthly2020-07-23 20:21
https://xconomy.com/san-francisco/2020/07/23/parker-institute-for-cancer-immunotherapy-adds-new-chief-scientific-officer/60%Monthly2020-07-23 16:59
https://xconomy.com/europe/2020/07/22/jazz-pharma-gets-fda-nod-for-new-drug-to-treat-narcolepsy-symptoms/60%Monthly2020-07-23 17:13
https://xconomy.com/boston/2020/07/22/vesigen-nabs-28m-to-wrap-armms-around-large-molecule-drug-delivery/60%Monthly2020-07-23 22:04
https://xconomy.com/san-francisco/2020/07/22/seer-raises-55m-to-commercialize-tools-to-analyze-the-proteome/60%Monthly2020-07-22 19:36
https://xconomy.com/san-francisco/2020/07/22/olema-adds-54m-to-start-human-tests-of-breast-cancer-drug-candidate/60%Monthly2020-07-22 13:50
https://xconomy.com/europe/2020/07/21/freeline-therapeutics-and-checkmate-pharma-make-opening-ipo-moves/60%Monthly2020-08-07 02:43
https://xconomy.com/new-york/2020/07/21/elevation-oncology-debuts-with-32-5m-to-develop-targeted-cancer-drugs/60%Monthly2020-07-21 19:00
https://xconomy.com/boston/2020/07/21/roche-jnana-enter-drug-rd-alliance-targeting-metabolisms-gatekeepers/60%Monthly2020-07-21 16:04
https://xconomy.com/san-francisco/2020/07/21/gilead-sciences-splashes-out-300m-for-tizona-stake-option-to-acquire/60%Monthly2020-07-21 11:56
https://xconomy.com/san-diego/2020/07/21/acadia-halts-work-on-depression-drug-after-late-stage-trial-failure/60%Monthly2020-07-21 11:58
https://xconomy.com/national/2020/07/21/forge-bios-combo-model-for-gene-therapies-attracts-40m-in-funding/60%Monthly2020-07-21 11:27
https://xconomy.com/boston/2020/07/20/rhythm-pharma-taps-chairman-david-meeker-as-president-ceo/60%Monthly2020-07-20 23:51
https://xconomy.com/europe/2020/07/20/tizonas-karakunnel-joins-innate-pharma-as-chief-medical-officer/60%Monthly2020-07-20 23:44
https://xconomy.com/europe/2020/07/20/gsk-pays-curevac-328m-in-mrna-vaccines-pact-excluding-covid-19/60%Monthly2020-07-20 14:19
https://xconomy.com/san-diego/2020/07/17/exalys-launches-with-15m-to-treat-postoperative-delirium-more/60%Monthly2020-07-20 20:23
https://xconomy.com/new-york/2020/07/17/meiragtx-jj-see-phase-3-test-ahead-for-vision-loss-gene-therapy/60%Monthly2020-07-23 21:22
https://xconomy.com/national/2020/07/17/two-days-six-ipos-and-1b-raised-for-biotech-research-more/60%Monthly2020-07-17 20:52
https://xconomy.com/national/2020/07/17/the-xcelerate-keynote-series-part-of-biotech-week-boston/60%Monthly2020-07-30 14:39
https://xconomy.com/national/2020/07/17/bio-roundup-moderna-publishes-life-science-cash-adcomm-votes-more/60%Monthly2020-07-17 15:32
https://xconomy.com/boston/2020/07/16/gsk-vaccine-vet-pfefer-tapped-for-executive-roles-at-flagship-kintai/60%Monthly2020-07-16 22:33
https://xconomy.com/boston/2020/07/16/adimab-spinout-adagio-raises-50m-for-coronavirus-antibody-rd/60%Monthly2020-07-16 17:49
https://xconomy.com/europe/2020/07/16/mallinckrodts-kidney-failure-drug-narrowly-wins-backing-of-fda-panel/60%Monthly2020-07-16 20:25
https://xconomy.com/boston/2020/07/15/moderna-publishes-early-covid-19-vaccine-data-preps-for-phase-3-test/60%Monthly2020-07-15 19:25
https://xconomy.com/boston/2020/07/15/last-chance-for-xconomy-awards-nominations-deadline-is-friday-july-17/60%Monthly2020-07-15 12:28
https://xconomy.com/boston/2020/07/15/dewpoint-merck-team-up-to-tackle-hiv-using-condensate-know-how/60%Monthly2020-07-15 11:39
https://xconomy.com/boston/2020/07/14/scholar-rock-ceo-mahanthappa-to-step-down-kingsley-named-successor/60%Monthly2020-07-14 21:42
https://xconomy.com/san-diego/2020/07/14/after-biologic-covid-19-drug-okd-in-india-equillium-plans-a-us-test/60%Monthly2020-07-14 21:38
https://xconomy.com/boston/2020/07/14/vor-biopharma-makes-slapaks-chief-medical-officer-job-permanent/60%Monthly2020-07-14 21:33
https://xconomy.com/national/2020/07/14/the-2020-national-xconomy-awards-2/60%Monthly2020-07-30 14:39
https://xconomy.com/boston/2020/07/14/roche-blueprint-medicines-team-up-again-in-775m-ret-cancer-drug-pact/60%Monthly2020-07-14 18:59
https://xconomy.com/boston/2020/07/14/new-xconomy-podcast-special-report-feature-boston-biophama-leaders-on-digital-health/60%Monthly2020-07-14 12:52
https://xconomy.com/san-diego/2020/07/13/turning-point-names-centrexions-partridge-as-chief-commercial-officer/60%Monthly2020-07-14 02:05
https://xconomy.com/san-francisco/2020/07/13/amgen-doubles-down-on-beigene-collaboration-investing-421m-more/60%Monthly2020-07-14 13:00
https://xconomy.com/national/2020/07/13/3-biotech-ipos-together-rake-in-over-a-half-billion-to-advance-treatments/60%Monthly2020-07-14 12:52
https://xconomy.com/san-diego/2020/07/13/viacyte-taps-insulets-bradrick-as-its-first-chief-financial-officer/60%Monthly2020-07-16 18:06
https://xconomy.com/europe/2020/07/13/kiadis-pharma-brings-on-e-therapeutics-barlow-as-chief-business-officer/60%Monthly2020-07-13 17:24
https://xconomy.com/boston/2020/07/13/ovid-licenses-european-rights-to-lead-rare-disease-drug-to-angelini-pharma/60%Monthly2020-07-13 15:20
https://xconomy.com/national/2020/07/10/bio-roundup-blackstones-billions-biogen-finishes-filing-novavax-at-warp-speed-more/60%Monthly2020-07-10 12:15
https://xconomy.com/boston/2020/07/09/sanofi-pays-kymera-150m-to-kick-off-protein-degrader-partnership/60%Monthly2020-07-10 17:36
https://xconomy.com/philadelphia/2020/07/09/nflection-looks-to-erase-nf1-tumors-with-drug-that-only-goes-skin-deep/60%Monthly2020-07-09 04:34
https://xconomy.com/san-diego/2020/07/09/cend-therapeutics-names-viractas-david-slack-as-its-new-president-ceo/60%Monthly2020-07-09 05:04
https://xconomy.com/san-diego/2020/07/09/kinnate-adds-wuxi-nextcodes-richard-williams-as-chief-medical-officer/60%Monthly2020-07-09 04:42
https://xconomy.com/san-diego/2020/07/09/velosbio-tacks-on-137m-to-advance-its-ror1-targeting-cancer-antibody-drugs/60%Monthly2020-07-09 16:28
https://xconomy.com/boston/2020/07/08/biogen-alzheimers-drug-in-fdas-court-following-completion-of-filing/60%Monthly2020-07-08 22:51
https://xconomy.com/national/2020/07/08/2020-national-xconomy-awards-expands-goes-virtual-reopens-nomination-period/60%Monthly2020-07-22 20:53
https://xconomy.com/boston/2020/07/08/foghorn-therapeutics-inks-chromatin-targeting-cancer-deal-with-merck/60%Monthly2020-07-08 17:17
https://xconomy.com/national/2020/07/07/novavax-gets-1-6b-in-operation-warp-speed-funding-for-covid-19-vaccine/60%Monthly2020-07-07 21:18
https://xconomy.com/boston/2020/07/07/cyteir-adds-chief-scientific-officer-chief-business-officer-to-c-suite/60%Monthly2020-07-07 17:03
https://xconomy.com/boston/2020/07/07/vor-nabs-110m-to-spare-healthy-cells-from-targeted-cancer-drugs/60%Monthly2020-07-08 22:35
https://xconomy.com/national/2020/07/07/pacbio-ceo-cfo-plan-retirements-and-more-people-on-the-move/60%Monthly2020-07-07 05:58
https://xconomy.com/san-francisco/2020/07/06/on-heels-of-100m-financing-annexon-bio-aims-to-tack-on-more-via-ipo/60%Monthly2020-07-06 17:11
https://xconomy.com/boston/2020/07/06/bristol-myers-pays-dragonfly-55m-to-bring-nk-cells-to-neuro-diseases/60%Monthly2020-07-06 16:09
https://xconomy.com/san-diego/2020/07/02/mei-pharma-helsinn-scuttle-cancer-drug-trial-after-miss-on-efficacy/60%Monthly2020-07-02 21:48
https://xconomy.com/national/2020/07/02/moderna-speed-of-covid-19-vaccine-hinges-on-enrolling-right-patients/60%Monthly2020-07-02 16:54
https://xconomy.com/san-francisco/2020/07/02/data-quantity-complexity-drives-use-of-ai-in-drug-discovery-and-testing/60%Monthly2020-07-06 16:54
https://xconomy.com/san-francisco/2020/07/01/annexon-adds-on-100m-to-advance-antibodies-to-treat-neurodegeneration/60%Monthly2020-07-06 07:08
https://xconomy.com/europe/2020/07/01/biontechs-mrna-covid-19-vaccine-shows-early-signs-of-sparking-immunity/60%Monthly2020-07-27 21:43
https://xconomy.com/boston/2020/07/01/amylyx-adds-30m-to-press-on-with-neuro-drug-for-als-alzheimers/60%Monthly2020-07-01 20:55
https://xconomy.com/san-francisco/2020/07/01/bolt-bio-adds-93-5m-to-move-ahead-immune-stimulating-cancer-drugs/60%Monthly2020-07-01 16:46
https://xconomy.com/boston/2020/07/01/chiesi-licenses-bioasis-tech-to-tackle-brain-symptoms-of-rare-diseases/60%Monthly2020-07-01 11:40
https://xconomy.com/san-francisco/2020/06/30/ultragenyx-pharma-wins-fdas-first-drug-nod-for-rare-metabolic-disorder/60%Monthly2020-07-01 13:12